{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T08:08:21Z","timestamp":1768637301649,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T00:00:00Z","timestamp":1487116800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00204-016-1923-4","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T20:33:17Z","timestamp":1487104397000},"page":"2443-2453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Dose\u2013response relationship of temozolomide, determined by the Pig-a, comet, and micronucleus assay"],"prefix":"10.1007","volume":"91","author":[{"given":"M.","family":"Gu\u00e9rard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Dertinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Duran-Pacheco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Funk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,15]]},"reference":[{"key":"1923_CR1","doi-asserted-by":"publisher","unstructured":"AMU EFSA (2009) Guidance of the Scientific Committee on Use of the benchmark dose approach in risk assessment. 1:72. doi: 10.2903\/j.efsa.2009.1150","DOI":"10.2903\/j.efsa.2009.1150"},{"issue":"6","key":"1923_CR2","first-page":"545","volume":"12","author":"WJ Bodell","year":"2003","unstructured":"Bodell WJ, Gaikwad NW, Miller D, Berger MS (2003) Formation of DNA adducts and induction of lacI mutations in Big Blue Rat-2 cells treated with temozolomide: implications for the treatment of low-grade adult and pediatric brain tumors. Cancer epidemiology, biomarkers and prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Int Soc Cell 12(6):545\u2013551","journal-title":"Int Soc Cell"},{"issue":"1","key":"1923_CR3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mrgentox.2006.08.011","volume":"627","author":"B Burlinson","year":"2007","unstructured":"Burlinson B, Tice RR, Speit G et al (2007) Fourth International Workgroup on Genotoxicity testing: results of the in vivo Comet assay workgroup. Mutat Res 627(1):31\u201335","journal-title":"Mutat Res"},{"issue":"18","key":"1923_CR4","doi-asserted-by":"publisher","first-page":"8403","DOI":"10.1093\/nar\/gkt635","volume":"41","author":"M Christmann","year":"2013","unstructured":"Christmann M, Kaina B (2013) Transcriptional regulation of human DNA repair genes following genotoxic stress: trigger mechanisms, inducible responses and genotoxic adaptation. NuclAcids Res 41(18):8403\u20138420 doi: 10.1093\/nar\/gkt635","journal-title":"NuclAcids Res"},{"issue":"2","key":"1923_CR5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0272-0590(87)90049-2","volume":"9","author":"MJ Derelanko","year":"1987","unstructured":"Derelanko MJ (1987) Determination of erythrocyte life span in F-344, Wistar, and Sprague\u2013Dawley rats using a modification of the [3H]diisopropylfluorophosphate ([3H]DFP) method. Fundam Appl Toxicol 9(2):271\u2013276","journal-title":"Fundam Appl Toxicol"},{"issue":"8","key":"1923_CR6","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1158\/0008-5472.can-06-4061","volume":"67","author":"SH Doak","year":"2007","unstructured":"Doak SH, Jenkins GJS, Johnson GE, Quick E, Parry EM, Parry JM (2007) Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. Cancer Res 67(8):3904\u20133911. doi: 10.1158\/0008-5472.can-06-4061","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"1923_CR7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mrgentox.2011.06.005","volume":"725","author":"KL Dobo","year":"2011","unstructured":"Dobo KL, Fiedler RD, Gunther WC et al (2011) Defining EMS and ENU dose\u2013response relationships using the Pig-a mutation assay in rats. Mutat Res 725(1\u20132):13\u201321","journal-title":"Mutat Res"},{"key":"1923_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-35374-1_46","author":"L Edler","year":"2014","unstructured":"Edler L (2014) Extrapolation-procedures for carcinogenic and noncarcinogenic compounds. Regul Toxicol. doi: 10.1007\/978-3-642-35374-1_46","journal-title":"Regul Toxicol"},{"issue":"7","key":"1923_CR9","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1182\/blood-2005-09-3649","volume":"107","author":"H Geiger","year":"2006","unstructured":"Geiger H, Schleimer D, Nattamai KJ, Dannenmann SR, Davies SM, Weiss BD (2006) Mutagenic potential of temozolomide in bone marrow cells in vivo. Blood 107(7):3010\u20133011","journal-title":"Blood"},{"issue":"2","key":"1923_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.mrgentox.2009.04.005","volume":"678","author":"E Gocke","year":"2009","unstructured":"Gocke E, M\u00fcller L (2009) In vivo studies in the mouse to define a threshold for the genotoxicity of EMS and ENU. Mutat Res 678(2):101\u2013107. doi: 10.1016\/j.mrgentox.2009.04.005","journal-title":"Mutat Res"},{"key":"1923_CR11","doi-asserted-by":"publisher","unstructured":"Gocke E, Ballantyne M, Whitwell J, M\u00fcller L (2009) MNT and Muta TM Mouse studies to define the in vivo dose response relations of the genotoxicity of EMS and ENU. 190:286\u2013297 doi: 10.1016\/j.toxlet.2009.03.021","DOI":"10.1016\/j.toxlet.2009.03.021"},{"issue":"1","key":"1923_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/em.21727","volume":"54","author":"BB Gollapudi","year":"2013","unstructured":"Gollapudi BB, Johnson GE, Hernandez LG et al (2013) Quantitative approaches for assessing dose\u2013response relationships in genetic toxicology studies. Environ Mol Mutagen 54(1):8\u201318. doi: 10.1002\/em.21727","journal-title":"Environ Mol Mutagen"},{"key":"1923_CR13","doi-asserted-by":"publisher","unstructured":"Gu\u00e9rard M, Baum M, Bitsch A et al (2015) Assessment of mechanisms driving non-linear dose\u2013response relationships in genotoxicity testing. Mutat Res Rev Mutat Res 763. doi: 10.1016\/j.mrrev.2014.11.001","DOI":"10.1016\/j.mrrev.2014.11.001"},{"issue":"1","key":"1923_CR14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/mutage\/18.1.45","volume":"18","author":"A Hartmann","year":"2003","unstructured":"Hartmann A, Agurell E, Beevers C et al (2003) Recommendations for conducting the in vivo alkaline Comet assay. 4th International Comet Assay Workshop. Mutagenesis 18(1):45\u201351","journal-title":"Mutagenesis"},{"key":"1923_CR15","doi-asserted-by":"publisher","unstructured":"Hayashi M, Tice RR, MacGregor JT et al (1994) In vivo rodent erythrocyte micronucleus assay. Mutat Res 312(293\u2013304) doi: 10.1016\/0165-1161(94)90039-6","DOI":"10.1016\/0165-1161(94)90039-6"},{"key":"1923_CR16","unstructured":"JaCVAM (2013) Report of the JaCVAM initiative international pre-validation studies of the in vivo rodent alkaline Comet assay for the detection of genotoxic carcinogens, version 1.4. http:\/\/www.oecdorg\/env\/ehs\/testing\/Come%20assay%20revised%20pre-validation%20report%202013pdf"},{"issue":"4","key":"1923_CR17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3123\/jemsge.34.179","volume":"34","author":"GE Johnson","year":"2012","unstructured":"Johnson GE, Zair Z, Bodger OG et al (2012) Investigating mechanisms for non-linear genotoxic responses, and analysing their effects in binary combination. Genes Environment 34(4):179\u2013185","journal-title":"Genes Environment"},{"key":"1923_CR18","doi-asserted-by":"crossref","unstructured":"Johnson GE, Soeteman-Hernandez LG, Gollapudi BB et al (2014) Derivation of point of departure (PoD) estimates in genetic toxicology studies and their potential applications in risk assessment. Environ Mol Mutagen","DOI":"10.1002\/em.21870"},{"key":"1923_CR19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0079-6603(01)68088-7","volume":"66","author":"B Kaina","year":"2001","unstructured":"Kaina B, Ochs K, Groesch S et al (2001) BER, MGMT and MMR in defense against alkylation-induced genotoxicity and apoptosis. Prog Nucleic Acid Res Mol Biol 66:41\u201354","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"1923_CR20","unstructured":"Litron (2009) Rat Pig-A mutation, analysis by flow cytometry, instruction manual"},{"key":"1923_CR21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0165-1218(87)90016-4","volume":"189","author":"JT MacGregor","year":"1987","unstructured":"MacGregor JT, Heddle JA, Hite M et al (1987) Guidelines for the conduct of micronucleus assays in mammalian bone marrow erythrocytes. Mutat Res 189:103\u2013112","journal-title":"Mutat Res"},{"key":"1923_CR22","doi-asserted-by":"crossref","unstructured":"MacGregor JT, Frotschl R, White PA et al (2015a) IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of point-of-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk. Mutat Res Genet Toxicol Environ Mutagen 783:66\u201378","DOI":"10.1016\/j.mrgentox.2014.10.008"},{"key":"1923_CR23","doi-asserted-by":"crossref","unstructured":"MacGregor JT, Frotschl R, White PA et al (2015b) IWGT report on quantitative approaches to genotoxicity risk assessment I. Methods and metrics for defining exposure\u2013response relationships and points of departure (PoDs). Mutat Res Genet Toxicol Environ Mutagen 783:55\u201365","DOI":"10.1016\/j.mrgentox.2014.09.011"},{"issue":"1","key":"1923_CR24","first-page":"29","volume":"239","author":"KH Mavournin","year":"1990","unstructured":"Mavournin KH, Blakey DH, Cimino MC, Salamone MF, Heddle JA (1990) The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the US Environmental Protection Agency Gene-Tox Program. Mutation Research\/Reviews in Genetic. Toxicology 239(1):29\u201380","journal-title":"Toxicology"},{"key":"1923_CR25","doi-asserted-by":"crossref","unstructured":"Muto S, Yamada K, Kato T et al (2016) Evaluation of the mutagenicity of alkylating agents, methylnitrosourea and temozolomide, using the rat Pig-a assay with total red blood cells or reticulocytes. Mutation Res Genet Toxicol Environ Mutagen (in press)","DOI":"10.1016\/j.mrgentox.2016.01.010"},{"key":"1923_CR37","unstructured":"OECD, 474 (2014) OECD guideline for the testing of chemicals: Mammalian Erythrocyte Micronucleus Test"},{"issue":"5","key":"1923_CR26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/00498250410001685737","volume":"34","author":"L Reyderman","year":"2004","unstructured":"Reyderman L, Statkevich P, Thonoor CM, Patrick J, Batra VK, Wirth M (2004) Disposition and pharmacokinetics of temozolomide in rat. Xenobiotica 34(5):487\u2013500","journal-title":"Xenobiotica"},{"issue":"12","key":"1923_CR27","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1289\/ehp.1003327","volume":"119","author":"S Sand","year":"2011","unstructured":"Sand S, Portier CJ, Krewski D (2011) A signal-to-noise crossover dose as the point of departure for health risk assessment. Environ Health Perspect 119(12):1766\u20131774","journal-title":"Environ Health Perspect"},{"issue":"3","key":"1923_CR28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3109\/10408444.2013.853726","volume":"44","author":"W Slob","year":"2014","unstructured":"Slob W, Setzer RW (2014) Shape and steepness of toxicological dose\u2013response relationships of continuous endpoints. Crit Rev Toxicol 44(3):270\u2013297","journal-title":"Crit Rev Toxicol"},{"key":"1923_CR29","unstructured":"Swiss Animal Welfare Law (Tierschutzgesetz DT) 2005"},{"key":"1923_CR30","doi-asserted-by":"publisher","unstructured":"Tang L, Singer T, Gocke E (2012) Dose\u2013response of alkylating agents in DNA repair-proficient and -deficient Ames tester strains. Mutagenesis 27(6) doi: 10.1093\/mutage\/ges061","DOI":"10.1093\/mutage\/ges061"},{"issue":"3","key":"1923_CR31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J","volume":"35","author":"RR Tice","year":"2000","unstructured":"Tice RR, Agurell E, Anderson D et al (2000) Single cell gel\/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35(3):206\u2013221","journal-title":"Environ Mol Mutagen"},{"key":"1923_CR32","unstructured":"Tierschutzgesetz (2005) (Swiss animal welfare law). Federal veterinary office"},{"issue":"3","key":"1923_CR33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00280-003-0660-6","volume":"52","author":"P Vernole","year":"2003","unstructured":"Vernole P, Pepponi R, D\u2019Atri S (2003) Role of mismatch repair in the induction of chromosomal aberrations and sister chromatid exchanges in cells treated with different chemotherapeutic agents. Cancer Chemother Pharmacol 52(3):185\u2013192","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"1923_CR34","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/toxsci\/kfq341","volume":"119","author":"ZM Za\u00efr","year":"2011","unstructured":"Za\u00efr ZM, Jenkins GJ, Doak SH, Singh R, Brown K, Johnson GE (2011) N-methylpurine DNA glycosylase plays a pivotal role in the threshold response of ethyl methanesulfonate-induced chromosome damage. Toxicol Sci Off J Soc Toxicol 119(2):346\u2013358. doi: 10.1093\/toxsci\/kfq341","journal-title":"Toxicol Sci Off J Soc Toxicol"},{"key":"1923_CR35","doi-asserted-by":"crossref","unstructured":"Zeller A, Tang L, Dertinger SD, Funk J, Duran-Pacheco G, Guerard M (2015) A proposal for a novel rationale for critical effect size in dose\u2013response analysis based on a multi-endpoint in vivo study with methyl methanesulfonate. Mutagenesis","DOI":"10.1093\/mutage\/gev077"},{"issue":"1","key":"1923_CR36","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1874467211205010102","volume":"5","author":"J Zhang","year":"2012","unstructured":"Zhang J, Stevens MF, Bradshaw TD (2012) Temozolomide: mechanisms of action, repair and resistance. Curr Mol Pharmacol 5(1):102\u2013114","journal-title":"Curr Mol Pharmacol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-016-1923-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-016-1923-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-016-1923-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T13:51:10Z","timestamp":1568814670000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-016-1923-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,15]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["1923"],"URL":"https:\/\/doi.org\/10.1007\/s00204-016-1923-4","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,15]]}}}